| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Valve Diseases | 61 | 2021 | 1030 | 9.140 |
Why?
|
| Aortic Valve | 73 | 2020 | 1969 | 8.750 |
Why?
|
| Aortic Aneurysm | 44 | 2022 | 649 | 7.150 |
Why?
|
| Heart Valve Prosthesis Implantation | 76 | 2021 | 1568 | 5.420 |
Why?
|
| Aortic Aneurysm, Thoracic | 39 | 2023 | 709 | 4.740 |
Why?
|
| Aorta, Thoracic | 33 | 2024 | 1112 | 4.420 |
Why?
|
| Aorta | 25 | 2023 | 2046 | 3.980 |
Why?
|
| Coronary Artery Bypass | 56 | 2021 | 2194 | 3.650 |
Why?
|
| Heart Valve Prosthesis | 46 | 2021 | 1468 | 3.470 |
Why?
|
| Cardiac Surgical Procedures | 57 | 2024 | 3681 | 3.440 |
Why?
|
| Blood Vessel Prosthesis Implantation | 26 | 2018 | 1459 | 2.890 |
Why?
|
| Thoracic Surgery | 16 | 2024 | 727 | 2.770 |
Why?
|
| Aortic Diseases | 20 | 2015 | 741 | 2.360 |
Why?
|
| Vascular Surgical Procedures | 28 | 2021 | 1515 | 2.350 |
Why?
|
| Mitral Valve Insufficiency | 30 | 2021 | 1414 | 2.260 |
Why?
|
| Cardiovascular Surgical Procedures | 11 | 2013 | 193 | 2.120 |
Why?
|
| Postoperative Complications | 117 | 2024 | 15881 | 1.900 |
Why?
|
| Aortic Rupture | 12 | 2016 | 322 | 1.800 |
Why?
|
| Bioprosthesis | 20 | 2017 | 592 | 1.800 |
Why?
|
| Operating Rooms | 12 | 2018 | 799 | 1.780 |
Why?
|
| Cardiology | 13 | 2020 | 1701 | 1.770 |
Why?
|
| Mitral Valve | 29 | 2021 | 1474 | 1.710 |
Why?
|
| Endocarditis | 7 | 2018 | 352 | 1.650 |
Why?
|
| Heart Valves | 5 | 2021 | 284 | 1.570 |
Why?
|
| Patient Care Team | 17 | 2024 | 2529 | 1.520 |
Why?
|
| Aortic Valve Insufficiency | 18 | 2017 | 577 | 1.440 |
Why?
|
| Aortic Valve Stenosis | 25 | 2018 | 2034 | 1.430 |
Why?
|
| Endarterectomy | 45 | 2011 | 196 | 1.420 |
Why?
|
| American Heart Association | 14 | 2020 | 1051 | 1.400 |
Why?
|
| Cardiopulmonary Bypass | 18 | 2024 | 1097 | 1.370 |
Why?
|
| Sinus of Valsalva | 6 | 2016 | 60 | 1.350 |
Why?
|
| Marfan Syndrome | 11 | 2015 | 237 | 1.350 |
Why?
|
| Hematoma | 9 | 2014 | 768 | 1.310 |
Why?
|
| Medical Errors | 9 | 2018 | 1263 | 1.250 |
Why?
|
| Carotid Artery Diseases | 54 | 2007 | 878 | 1.210 |
Why?
|
| Atrial Fibrillation | 24 | 2019 | 5168 | 1.210 |
Why?
|
| Dilatation, Pathologic | 16 | 2016 | 527 | 1.130 |
Why?
|
| Treatment Outcome | 134 | 2024 | 65379 | 1.000 |
Why?
|
| Humans | 521 | 2024 | 768393 | 1.000 |
Why?
|
| Practice Guidelines as Topic | 15 | 2019 | 7453 | 0.990 |
Why?
|
| Aortic Coarctation | 4 | 2018 | 278 | 0.990 |
Why?
|
| Reoperation | 45 | 2021 | 4341 | 0.940 |
Why?
|
| Guideline Adherence | 7 | 2016 | 2240 | 0.940 |
Why?
|
| Postoperative Care | 15 | 2015 | 1480 | 0.920 |
Why?
|
| Cerebrovascular Circulation | 72 | 2013 | 2736 | 0.880 |
Why?
|
| Endocarditis, Bacterial | 3 | 2018 | 436 | 0.880 |
Why?
|
| Patient Selection | 23 | 2021 | 4266 | 0.870 |
Why?
|
| Myocardial Ischemia | 10 | 2017 | 2139 | 0.850 |
Why?
|
| Embolectomy | 4 | 2016 | 130 | 0.850 |
Why?
|
| Ulcer | 5 | 2009 | 203 | 0.850 |
Why?
|
| Massage | 5 | 2010 | 86 | 0.850 |
Why?
|
| Ischemic Attack, Transient | 56 | 1997 | 877 | 0.830 |
Why?
|
| Tricuspid Valve Insufficiency | 8 | 2019 | 362 | 0.820 |
Why?
|
| Male | 342 | 2024 | 364902 | 0.820 |
Why?
|
| Evidence-Based Medicine | 12 | 2021 | 3707 | 0.810 |
Why?
|
| Aged | 237 | 2024 | 171562 | 0.810 |
Why?
|
| Angiography | 13 | 2019 | 1598 | 0.810 |
Why?
|
| Blood Vessel Prosthesis | 13 | 2017 | 957 | 0.800 |
Why?
|
| Consensus | 11 | 2021 | 3212 | 0.790 |
Why?
|
| Pulmonary Embolism | 10 | 2017 | 2587 | 0.790 |
Why?
|
| Echocardiography | 19 | 2019 | 5044 | 0.790 |
Why?
|
| Minnesota | 23 | 2012 | 338 | 0.770 |
Why?
|
| Middle Aged | 251 | 2024 | 223491 | 0.770 |
Why?
|
| Mammary Arteries | 5 | 2011 | 82 | 0.760 |
Why?
|
| Female | 321 | 2024 | 397089 | 0.740 |
Why?
|
| Risk Assessment | 52 | 2024 | 24318 | 0.720 |
Why?
|
| Prosthesis Failure | 13 | 2016 | 1208 | 0.720 |
Why?
|
| Thoracic Surgical Procedures | 5 | 2016 | 350 | 0.700 |
Why?
|
| Intracranial Aneurysm | 39 | 1993 | 1293 | 0.680 |
Why?
|
| Registries | 29 | 2024 | 8379 | 0.680 |
Why?
|
| Uncertainty | 2 | 2015 | 759 | 0.670 |
Why?
|
| Safety Management | 5 | 2011 | 765 | 0.670 |
Why?
|
| Malus | 1 | 2020 | 51 | 0.670 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2012 | 1724 | 0.650 |
Why?
|
| Quality Assurance, Health Care | 5 | 2019 | 2181 | 0.640 |
Why?
|
| Arterial Occlusive Diseases | 27 | 2001 | 746 | 0.640 |
Why?
|
| Pericarditis, Constrictive | 5 | 2011 | 46 | 0.640 |
Why?
|
| Subarachnoid Hemorrhage | 32 | 1993 | 1039 | 0.630 |
Why?
|
| Time Factors | 72 | 2024 | 40272 | 0.630 |
Why?
|
| Coronary Artery Disease | 18 | 2020 | 6567 | 0.630 |
Why?
|
| Myocardial Revascularization | 8 | 2015 | 796 | 0.630 |
Why?
|
| Task Performance and Analysis | 5 | 2018 | 771 | 0.630 |
Why?
|
| Graft Occlusion, Vascular | 6 | 2015 | 538 | 0.620 |
Why?
|
| Echocardiography, Doppler | 15 | 2019 | 899 | 0.620 |
Why?
|
| Intracranial Arteriovenous Malformations | 14 | 1994 | 366 | 0.620 |
Why?
|
| Catheter Ablation | 11 | 2013 | 2776 | 0.600 |
Why?
|
| Lung Transplantation | 8 | 2021 | 1309 | 0.600 |
Why?
|
| Mitral Valve Annuloplasty | 5 | 2021 | 145 | 0.600 |
Why?
|
| Heart Conduction System | 6 | 2013 | 1009 | 0.590 |
Why?
|
| Clinical Competence | 10 | 2024 | 4848 | 0.590 |
Why?
|
| Replantation | 3 | 2018 | 145 | 0.570 |
Why?
|
| Risk Factors | 83 | 2024 | 74962 | 0.560 |
Why?
|
| Cerebrovascular Disorders | 43 | 2003 | 1486 | 0.560 |
Why?
|
| Advisory Committees | 3 | 2017 | 797 | 0.550 |
Why?
|
| Aged, 80 and over | 84 | 2020 | 59686 | 0.550 |
Why?
|
| Systems Analysis | 2 | 2008 | 168 | 0.550 |
Why?
|
| Education, Medical, Graduate | 4 | 2018 | 2412 | 0.540 |
Why?
|
| Hyperglycemia | 3 | 2014 | 1389 | 0.540 |
Why?
|
| Retrospective Studies | 112 | 2024 | 81801 | 0.540 |
Why?
|
| Paraplegia | 5 | 2011 | 161 | 0.540 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 2 | 2011 | 38 | 0.540 |
Why?
|
| Societies, Medical | 6 | 2024 | 3960 | 0.540 |
Why?
|
| Heart Arrest, Induced | 5 | 2011 | 361 | 0.530 |
Why?
|
| Hospital Mortality | 30 | 2022 | 5367 | 0.530 |
Why?
|
| Anticoagulants | 11 | 2017 | 4843 | 0.530 |
Why?
|
| Drainage | 3 | 2013 | 1184 | 0.520 |
Why?
|
| Vascular Neoplasms | 3 | 2012 | 167 | 0.510 |
Why?
|
| Medical Staff, Hospital | 2 | 2018 | 603 | 0.510 |
Why?
|
| Survival Rate | 37 | 2020 | 12870 | 0.490 |
Why?
|
| Heart Ventricles | 12 | 2011 | 3838 | 0.490 |
Why?
|
| Follow-Up Studies | 66 | 2020 | 39407 | 0.480 |
Why?
|
| Aneurysm, False | 4 | 2012 | 263 | 0.470 |
Why?
|
| Pulmonary Fibrosis | 2 | 2018 | 506 | 0.470 |
Why?
|
| Ischemia | 23 | 2022 | 1900 | 0.460 |
Why?
|
| Endovascular Procedures | 5 | 2018 | 2215 | 0.460 |
Why?
|
| Cerebral Arteries | 31 | 1994 | 489 | 0.460 |
Why?
|
| Ventricular Function, Left | 12 | 2018 | 3941 | 0.460 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2019 | 954 | 0.460 |
Why?
|
| Atrial Appendage | 1 | 2018 | 285 | 0.450 |
Why?
|
| Cardiac Care Facilities | 3 | 2019 | 35 | 0.450 |
Why?
|
| Preoperative Care | 13 | 2015 | 2258 | 0.450 |
Why?
|
| Erythrocyte Transfusion | 3 | 2015 | 575 | 0.450 |
Why?
|
| Hemostatics | 2 | 2008 | 246 | 0.450 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2019 | 4076 | 0.450 |
Why?
|
| Bicuspid | 3 | 2018 | 70 | 0.440 |
Why?
|
| Pulmonary Artery | 7 | 2011 | 1945 | 0.440 |
Why?
|
| Laser Therapy | 6 | 1999 | 1105 | 0.440 |
Why?
|
| Aprotinin | 3 | 2008 | 94 | 0.430 |
Why?
|
| Quality of Health Care | 4 | 2019 | 4339 | 0.430 |
Why?
|
| Hospitals, General | 2 | 2016 | 807 | 0.420 |
Why?
|
| Adult | 157 | 2022 | 223640 | 0.420 |
Why?
|
| Severity of Illness Index | 31 | 2019 | 15939 | 0.410 |
Why?
|
| Carotid Arteries | 30 | 2015 | 943 | 0.410 |
Why?
|
| Pericardiectomy | 3 | 2011 | 45 | 0.410 |
Why?
|
| Surgical Wound Infection | 6 | 2014 | 1545 | 0.400 |
Why?
|
| Interprofessional Relations | 5 | 2018 | 997 | 0.400 |
Why?
|
| Workload | 5 | 2019 | 852 | 0.390 |
Why?
|
| Disease Management | 4 | 2018 | 2537 | 0.390 |
Why?
|
| Benchmarking | 2 | 2016 | 1058 | 0.380 |
Why?
|
| Patient Transfer | 2 | 2017 | 793 | 0.380 |
Why?
|
| Prosthesis Design | 15 | 2021 | 2126 | 0.380 |
Why?
|
| Survival Analysis | 26 | 2018 | 10117 | 0.380 |
Why?
|
| Brain Edema | 13 | 2008 | 607 | 0.380 |
Why?
|
| Coitus | 1 | 2012 | 133 | 0.380 |
Why?
|
| Internship and Residency | 4 | 2018 | 5949 | 0.380 |
Why?
|
| Time Management | 2 | 2010 | 52 | 0.380 |
Why?
|
| Coronary Disease | 14 | 2011 | 5924 | 0.380 |
Why?
|
| Heart Diseases | 7 | 2019 | 2819 | 0.380 |
Why?
|
| Hemodynamics | 18 | 2021 | 4199 | 0.370 |
Why?
|
| Coronary Vasospasm | 1 | 2011 | 81 | 0.370 |
Why?
|
| Tricuspid Valve | 5 | 2019 | 419 | 0.370 |
Why?
|
| Probability | 15 | 2010 | 2482 | 0.370 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2016 | 530 | 0.370 |
Why?
|
| Hypothermia, Induced | 6 | 2011 | 756 | 0.370 |
Why?
|
| Emotions | 1 | 2023 | 2768 | 0.370 |
Why?
|
| Stress, Psychological | 5 | 2018 | 4543 | 0.360 |
Why?
|
| Angina Pectoris | 6 | 2007 | 960 | 0.360 |
Why?
|
| Anastomosis, Surgical | 8 | 2011 | 993 | 0.360 |
Why?
|
| Vascular Patency | 9 | 2011 | 916 | 0.360 |
Why?
|
| Blood Glucose | 4 | 2014 | 6430 | 0.360 |
Why?
|
| Embolism, Paradoxical | 1 | 2010 | 55 | 0.360 |
Why?
|
| Intracranial Hemorrhages | 1 | 2016 | 811 | 0.350 |
Why?
|
| Dobutamine | 2 | 2008 | 116 | 0.350 |
Why?
|
| Arteriosclerosis | 11 | 2004 | 1056 | 0.350 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 700 | 0.350 |
Why?
|
| Echocardiography, Transesophageal | 11 | 2013 | 1095 | 0.350 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 494 | 0.350 |
Why?
|
| Brain Ischemia | 20 | 2007 | 3008 | 0.340 |
Why?
|
| Tunica Intima | 1 | 2012 | 459 | 0.340 |
Why?
|
| Aortography | 8 | 2016 | 422 | 0.340 |
Why?
|
| Databases, Factual | 9 | 2024 | 8075 | 0.340 |
Why?
|
| Hypertension, Pulmonary | 4 | 2018 | 1597 | 0.330 |
Why?
|
| Pericardiocentesis | 1 | 2010 | 78 | 0.330 |
Why?
|
| Acute Disease | 21 | 2023 | 7242 | 0.330 |
Why?
|
| Sternotomy | 1 | 2010 | 132 | 0.330 |
Why?
|
| Coronary Stenosis | 3 | 2018 | 802 | 0.330 |
Why?
|
| Health Planning Guidelines | 1 | 2010 | 153 | 0.320 |
Why?
|
| Mitral Valve Prolapse | 5 | 2011 | 213 | 0.320 |
Why?
|
| Endarterectomy, Carotid | 3 | 2007 | 557 | 0.320 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2017 | 10377 | 0.320 |
Why?
|
| Age Factors | 27 | 2021 | 18471 | 0.310 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2009 | 128 | 0.310 |
Why?
|
| Interdisciplinary Communication | 3 | 2024 | 937 | 0.310 |
Why?
|
| Vasodilation | 5 | 2007 | 968 | 0.310 |
Why?
|
| Aneurysm, Ruptured | 2 | 2013 | 462 | 0.310 |
Why?
|
| Hypoglycemia | 2 | 2014 | 894 | 0.310 |
Why?
|
| Pulmonary Valve | 3 | 2015 | 413 | 0.300 |
Why?
|
| Coronary Sinus | 1 | 2009 | 85 | 0.300 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2020 | 518 | 0.300 |
Why?
|
| Spinal Cord Diseases | 1 | 2011 | 293 | 0.300 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 210 | 0.300 |
Why?
|
| Intraoperative Complications | 14 | 2015 | 1176 | 0.300 |
Why?
|
| Recurrence | 20 | 2021 | 8506 | 0.300 |
Why?
|
| Cerebral Angiography | 34 | 1994 | 1274 | 0.300 |
Why?
|
| Checklist | 1 | 2015 | 844 | 0.300 |
Why?
|
| Cerebral Revascularization | 11 | 1988 | 263 | 0.290 |
Why?
|
| Suture Techniques | 2 | 2017 | 777 | 0.290 |
Why?
|
| United States | 38 | 2024 | 73150 | 0.290 |
Why?
|
| Kaplan-Meier Estimate | 18 | 2018 | 6541 | 0.290 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 246 | 0.290 |
Why?
|
| Motivation | 1 | 2017 | 2029 | 0.290 |
Why?
|
| Radial Artery | 5 | 2006 | 188 | 0.290 |
Why?
|
| Receptor, Notch1 | 2 | 2007 | 520 | 0.290 |
Why?
|
| Echocardiography, Stress | 1 | 2008 | 139 | 0.290 |
Why?
|
| Multivariate Analysis | 19 | 2020 | 12092 | 0.290 |
Why?
|
| General Surgery | 3 | 2011 | 1713 | 0.280 |
Why?
|
| Mediastinum | 1 | 2008 | 272 | 0.280 |
Why?
|
| Perfusion | 6 | 2011 | 1402 | 0.280 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2011 | 497 | 0.280 |
Why?
|
| Swine, Miniature | 15 | 1994 | 965 | 0.280 |
Why?
|
| Tenascin | 1 | 2007 | 61 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2016 | 10776 | 0.280 |
Why?
|
| Halothane | 16 | 1988 | 200 | 0.270 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 552 | 0.270 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 364 | 0.270 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 148 | 0.270 |
Why?
|
| Carotid Artery, Internal | 25 | 1993 | 445 | 0.270 |
Why?
|
| Graft Rejection | 13 | 2018 | 4505 | 0.270 |
Why?
|
| Coronary Aneurysm | 1 | 2009 | 234 | 0.260 |
Why?
|
| Dogs | 23 | 2007 | 3846 | 0.260 |
Why?
|
| Stroke Volume | 14 | 2018 | 5619 | 0.260 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 258 | 0.260 |
Why?
|
| Prognosis | 29 | 2021 | 30022 | 0.260 |
Why?
|
| Thoracic Arteries | 3 | 2000 | 40 | 0.250 |
Why?
|
| Graft Survival | 13 | 2018 | 3900 | 0.250 |
Why?
|
| Safety | 3 | 2007 | 1159 | 0.250 |
Why?
|
| Stress, Mechanical | 7 | 2013 | 1680 | 0.250 |
Why?
|
| Leadership | 5 | 2018 | 1395 | 0.250 |
Why?
|
| Antihypertensive Agents | 3 | 2014 | 2027 | 0.250 |
Why?
|
| Carbon Dioxide | 23 | 1990 | 1149 | 0.250 |
Why?
|
| Quality Indicators, Health Care | 4 | 2024 | 1813 | 0.250 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3267 | 0.250 |
Why?
|
| Giant Cell Arteritis | 2 | 2009 | 307 | 0.250 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 4 | 2024 | 82 | 0.250 |
Why?
|
| Chi-Square Distribution | 10 | 2014 | 3438 | 0.250 |
Why?
|
| Cats | 30 | 1990 | 978 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 26 | 2016 | 20765 | 0.240 |
Why?
|
| Osteopontin | 1 | 2007 | 307 | 0.240 |
Why?
|
| Hydrogen-Ion Concentration | 16 | 1989 | 2488 | 0.240 |
Why?
|
| Genes, Homeobox | 1 | 2006 | 289 | 0.240 |
Why?
|
| Logistic Models | 17 | 2019 | 13323 | 0.240 |
Why?
|
| Basilar Artery | 12 | 1992 | 207 | 0.240 |
Why?
|
| Acupuncture Therapy | 1 | 2009 | 486 | 0.240 |
Why?
|
| Monitoring, Intraoperative | 2 | 2010 | 950 | 0.240 |
Why?
|
| Blood Loss, Surgical | 2 | 2008 | 643 | 0.240 |
Why?
|
| Sensitivity and Specificity | 13 | 2019 | 14737 | 0.230 |
Why?
|
| New York | 7 | 2020 | 884 | 0.230 |
Why?
|
| Length of Stay | 13 | 2018 | 6519 | 0.230 |
Why?
|
| Stroke | 13 | 2019 | 9742 | 0.230 |
Why?
|
| Intraoperative Period | 6 | 2011 | 513 | 0.230 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2011 | 1434 | 0.230 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 1226 | 0.220 |
Why?
|
| Electroencephalography | 29 | 2007 | 6317 | 0.220 |
Why?
|
| Genetic Heterogeneity | 1 | 2007 | 737 | 0.220 |
Why?
|
| Thrombosis | 10 | 2013 | 2955 | 0.220 |
Why?
|
| Decision Support Techniques | 2 | 2014 | 2006 | 0.220 |
Why?
|
| Heart Transplantation | 4 | 2022 | 3300 | 0.220 |
Why?
|
| Proportional Hazards Models | 19 | 2016 | 12558 | 0.220 |
Why?
|
| History, 20th Century | 5 | 2016 | 2771 | 0.220 |
Why?
|
| Saphenous Vein | 6 | 2009 | 519 | 0.220 |
Why?
|
| Tissue Adhesives | 1 | 2005 | 179 | 0.220 |
Why?
|
| Observation | 3 | 2010 | 311 | 0.210 |
Why?
|
| Cranial Sinuses | 5 | 1991 | 68 | 0.210 |
Why?
|
| Bacterial Infections | 1 | 2011 | 1397 | 0.210 |
Why?
|
| Medical Records | 1 | 2008 | 1412 | 0.210 |
Why?
|
| Constriction | 7 | 2011 | 168 | 0.210 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2008 | 640 | 0.210 |
Why?
|
| Coronary Angiography | 11 | 2020 | 4537 | 0.210 |
Why?
|
| Intra-Aortic Balloon Pumping | 3 | 2020 | 223 | 0.210 |
Why?
|
| Patient Satisfaction | 4 | 2010 | 3486 | 0.210 |
Why?
|
| Equipment Failure Analysis | 4 | 2011 | 848 | 0.210 |
Why?
|
| Insulin | 3 | 2014 | 6607 | 0.210 |
Why?
|
| Intracranial Embolism and Thrombosis | 17 | 1999 | 144 | 0.210 |
Why?
|
| Communication | 5 | 2018 | 3912 | 0.200 |
Why?
|
| Ventricular Function | 1 | 2004 | 406 | 0.200 |
Why?
|
| Heart Defects, Congenital | 6 | 2014 | 4713 | 0.200 |
Why?
|
| Intraoperative Care | 6 | 2007 | 771 | 0.200 |
Why?
|
| Incidence | 19 | 2016 | 21544 | 0.200 |
Why?
|
| Critical Care | 1 | 2015 | 2716 | 0.200 |
Why?
|
| Odds Ratio | 9 | 2018 | 9682 | 0.200 |
Why?
|
| Transplantation, Homologous | 9 | 2017 | 4834 | 0.200 |
Why?
|
| Myocardial Infarction | 17 | 2019 | 11516 | 0.200 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2002 | 81 | 0.190 |
Why?
|
| Brain | 41 | 2002 | 27454 | 0.190 |
Why?
|
| Arteriovenous Fistula | 6 | 1993 | 320 | 0.190 |
Why?
|
| Models, Organizational | 2 | 2019 | 548 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 3108 | 0.190 |
Why?
|
| Surgical Instruments | 5 | 1986 | 386 | 0.190 |
Why?
|
| Anxiety | 5 | 2011 | 4677 | 0.190 |
Why?
|
| Propensity Score | 3 | 2019 | 1962 | 0.190 |
Why?
|
| Warfarin | 4 | 2008 | 1493 | 0.190 |
Why?
|
| Polymorphism, Genetic | 4 | 2006 | 4250 | 0.190 |
Why?
|
| Craniotomy | 7 | 1992 | 747 | 0.190 |
Why?
|
| Elastic Tissue | 2 | 2015 | 66 | 0.180 |
Why?
|
| Spinal Cord | 3 | 2006 | 1813 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 843 | 0.180 |
Why?
|
| Atherosclerosis | 5 | 2015 | 3431 | 0.180 |
Why?
|
| Sarcoma | 1 | 2012 | 1807 | 0.180 |
Why?
|
| Quality Improvement | 2 | 2019 | 3858 | 0.180 |
Why?
|
| Predictive Value of Tests | 16 | 2019 | 15455 | 0.180 |
Why?
|
| Denervation | 2 | 1999 | 265 | 0.180 |
Why?
|
| Cardiovascular Agents | 5 | 2021 | 849 | 0.180 |
Why?
|
| Research Design | 4 | 2017 | 6210 | 0.180 |
Why?
|
| Coronary Vessels | 7 | 2020 | 3125 | 0.180 |
Why?
|
| Hepatitis C | 2 | 2021 | 1593 | 0.180 |
Why?
|
| Hemoptysis | 1 | 2001 | 152 | 0.180 |
Why?
|
| History, 21st Century | 2 | 2016 | 1575 | 0.170 |
Why?
|
| Fibromuscular Dysplasia | 4 | 1991 | 55 | 0.170 |
Why?
|
| Renal Insufficiency | 4 | 2011 | 809 | 0.170 |
Why?
|
| Sinoatrial Node | 1 | 2000 | 99 | 0.170 |
Why?
|
| Thoracotomy | 2 | 2004 | 374 | 0.170 |
Why?
|
| Methylprednisolone | 4 | 1993 | 387 | 0.170 |
Why?
|
| Acute Kidney Injury | 3 | 2024 | 1943 | 0.170 |
Why?
|
| Prospective Studies | 25 | 2016 | 54920 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2017 | 2144 | 0.170 |
Why?
|
| Diabetic Angiopathies | 1 | 2005 | 806 | 0.170 |
Why?
|
| Organizational Culture | 3 | 2018 | 512 | 0.170 |
Why?
|
| Postoperative Hemorrhage | 4 | 2016 | 419 | 0.170 |
Why?
|
| Ultrasonography | 9 | 2016 | 6001 | 0.170 |
Why?
|
| Takayasu Arteritis | 1 | 2001 | 105 | 0.160 |
Why?
|
| Therapeutic Irrigation | 3 | 2013 | 297 | 0.160 |
Why?
|
| Cavernous Sinus | 3 | 1993 | 122 | 0.160 |
Why?
|
| Skin Transplantation | 7 | 1995 | 1097 | 0.160 |
Why?
|
| Thromboembolism | 6 | 2008 | 1004 | 0.160 |
Why?
|
| Thrombolytic Therapy | 4 | 2016 | 2050 | 0.160 |
Why?
|
| Risk | 13 | 2017 | 9636 | 0.150 |
Why?
|
| Pentobarbital | 7 | 1983 | 153 | 0.150 |
Why?
|
| Suction | 1 | 1999 | 268 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2708 | 0.150 |
Why?
|
| Statistics, Nonparametric | 6 | 2011 | 2862 | 0.150 |
Why?
|
| Glottis | 1 | 1999 | 214 | 0.150 |
Why?
|
| Blood Flow Velocity | 12 | 2018 | 1376 | 0.150 |
Why?
|
| Animals | 125 | 2014 | 169337 | 0.150 |
Why?
|
| Dissection | 1 | 2000 | 299 | 0.150 |
Why?
|
| Haplorhini | 27 | 1979 | 524 | 0.150 |
Why?
|
| Cohort Studies | 18 | 2018 | 41795 | 0.150 |
Why?
|
| Neurosurgery | 5 | 1994 | 690 | 0.150 |
Why?
|
| Stents | 9 | 2011 | 3201 | 0.150 |
Why?
|
| Pacemaker, Artificial | 4 | 2015 | 828 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2005 | 2258 | 0.150 |
Why?
|
| Ultrasonic Therapy | 1 | 2000 | 217 | 0.150 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 114 | 0.150 |
Why?
|
| Cardiomyopathy, Restrictive | 2 | 2008 | 61 | 0.150 |
Why?
|
| Mandatory Reporting | 1 | 2018 | 123 | 0.150 |
Why?
|
| Models, Theoretical | 5 | 2019 | 3579 | 0.150 |
Why?
|
| Mesentery | 1 | 1998 | 202 | 0.150 |
Why?
|
| Mucus | 1 | 1999 | 346 | 0.140 |
Why?
|
| International Normalized Ratio | 2 | 2010 | 382 | 0.140 |
Why?
|
| Systems Theory | 2 | 2010 | 57 | 0.140 |
Why?
|
| Arteries | 5 | 1999 | 1126 | 0.140 |
Why?
|
| Calcium Channel Blockers | 5 | 1990 | 692 | 0.140 |
Why?
|
| Shock, Cardiogenic | 2 | 2015 | 711 | 0.140 |
Why?
|
| Myocardial Contraction | 3 | 2008 | 1527 | 0.140 |
Why?
|
| Systole | 4 | 2009 | 937 | 0.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2017 | 1482 | 0.140 |
Why?
|
| Nephrectomy | 2 | 2015 | 949 | 0.140 |
Why?
|
| Cerebral Hemorrhage | 11 | 1994 | 2653 | 0.140 |
Why?
|
| Ventricular Pressure | 1 | 2018 | 210 | 0.140 |
Why?
|
| Electrocardiography | 9 | 2017 | 6409 | 0.140 |
Why?
|
| Cerebral Cortex | 22 | 1989 | 5831 | 0.140 |
Why?
|
| Hypercapnia | 5 | 1990 | 260 | 0.140 |
Why?
|
| Endothelium | 4 | 1995 | 768 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 2429 | 0.140 |
Why?
|
| Exercise Test | 4 | 2014 | 2186 | 0.130 |
Why?
|
| Aortitis | 2 | 2009 | 77 | 0.130 |
Why?
|
| Ventricular Remodeling | 4 | 2011 | 1281 | 0.130 |
Why?
|
| Swine | 21 | 2011 | 5994 | 0.130 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 984 | 0.130 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2011 | 856 | 0.130 |
Why?
|
| Umbelliferones | 5 | 1987 | 12 | 0.130 |
Why?
|
| Europe | 8 | 2017 | 3439 | 0.130 |
Why?
|
| Seizures | 8 | 1990 | 3000 | 0.130 |
Why?
|
| Recovery of Function | 7 | 2021 | 2990 | 0.130 |
Why?
|
| Vascular Resistance | 3 | 2018 | 940 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2009 | 6277 | 0.130 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2007 | 65 | 0.130 |
Why?
|
| ROC Curve | 3 | 2015 | 3623 | 0.130 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 1993 | 187 | 0.130 |
Why?
|
| Brain Chemistry | 4 | 1986 | 962 | 0.130 |
Why?
|
| Hemodilution | 2 | 2015 | 120 | 0.130 |
Why?
|
| Allopurinol | 2 | 1987 | 198 | 0.130 |
Why?
|
| Blood Pressure | 29 | 1997 | 8541 | 0.130 |
Why?
|
| Nimodipine | 9 | 1990 | 57 | 0.120 |
Why?
|
| Transplantation, Autologous | 3 | 2015 | 2127 | 0.120 |
Why?
|
| Heart Function Tests | 1 | 1996 | 318 | 0.120 |
Why?
|
| Tunica Media | 1 | 2015 | 111 | 0.120 |
Why?
|
| NAD | 7 | 1980 | 618 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2012 | 353 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 2820 | 0.120 |
Why?
|
| Hyperemia | 4 | 1993 | 224 | 0.120 |
Why?
|
| Anesthesia, General | 7 | 1987 | 1186 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2008 | 1881 | 0.120 |
Why?
|
| Massachusetts | 6 | 2019 | 8902 | 0.120 |
Why?
|
| Heart | 2 | 1999 | 4449 | 0.120 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2015 | 130 | 0.120 |
Why?
|
| Vertebral Artery | 4 | 1981 | 185 | 0.120 |
Why?
|
| Causality | 3 | 2015 | 1255 | 0.120 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2008 | 1751 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2009 | 308 | 0.120 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.120 |
Why?
|
| Drug-Eluting Stents | 1 | 2020 | 681 | 0.120 |
Why?
|
| Coronary Circulation | 3 | 2022 | 1617 | 0.110 |
Why?
|
| Anesthesia, Intravenous | 1 | 1995 | 130 | 0.110 |
Why?
|
| History, 19th Century | 1 | 2016 | 715 | 0.110 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2018 | 346 | 0.110 |
Why?
|
| Self Care | 2 | 2010 | 797 | 0.110 |
Why?
|
| Regression Analysis | 3 | 2015 | 6350 | 0.110 |
Why?
|
| Hospitals, Teaching | 2 | 2018 | 1158 | 0.110 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 73 | 0.110 |
Why?
|
| Mortality | 4 | 2020 | 2917 | 0.110 |
Why?
|
| Microsurgery | 6 | 1986 | 803 | 0.110 |
Why?
|
| Curriculum | 2 | 2018 | 3776 | 0.110 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2014 | 51 | 0.110 |
Why?
|
| Dura Mater | 4 | 1991 | 297 | 0.110 |
Why?
|
| Death, Sudden | 1 | 2015 | 301 | 0.110 |
Why?
|
| Feasibility Studies | 5 | 2009 | 5313 | 0.110 |
Why?
|
| Bundle-Branch Block | 1 | 2015 | 278 | 0.110 |
Why?
|
| Adolescent | 41 | 2020 | 89184 | 0.110 |
Why?
|
| Pain | 7 | 2011 | 5103 | 0.110 |
Why?
|
| Major Histocompatibility Complex | 4 | 1993 | 877 | 0.110 |
Why?
|
| Risk Management | 2 | 2008 | 558 | 0.110 |
Why?
|
| Aneurysm | 5 | 2009 | 343 | 0.110 |
Why?
|
| Hemorrhage | 3 | 2016 | 3461 | 0.110 |
Why?
|
| Cardiovascular Diseases | 3 | 2010 | 15649 | 0.110 |
Why?
|
| Confidence Intervals | 5 | 2010 | 2931 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 1031 | 0.100 |
Why?
|
| Temporal Arteries | 6 | 1982 | 155 | 0.100 |
Why?
|
| Sternum | 3 | 2008 | 177 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3985 | 0.100 |
Why?
|
| Patient Care | 2 | 2010 | 629 | 0.100 |
Why?
|
| Radiography | 17 | 2005 | 6993 | 0.100 |
Why?
|
| Cytokines | 2 | 2007 | 7445 | 0.100 |
Why?
|
| Methods | 13 | 1985 | 1067 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 10 | 1983 | 694 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2015 | 703 | 0.100 |
Why?
|
| Regional Blood Flow | 13 | 2008 | 1502 | 0.100 |
Why?
|
| Embolization, Therapeutic | 2 | 2012 | 1410 | 0.100 |
Why?
|
| Pulse | 2 | 1991 | 218 | 0.100 |
Why?
|
| Comprehension | 1 | 2018 | 641 | 0.100 |
Why?
|
| Music Therapy | 2 | 2011 | 111 | 0.100 |
Why?
|
| Barbiturates | 3 | 1987 | 113 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2010 | 644 | 0.100 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2018 | 1092 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 4 | 1991 | 138 | 0.100 |
Why?
|
| Health Facility Environment | 1 | 2011 | 32 | 0.100 |
Why?
|
| Jugular Veins | 4 | 1989 | 211 | 0.100 |
Why?
|
| Isoproterenol | 7 | 1980 | 398 | 0.100 |
Why?
|
| Young Adult | 16 | 2020 | 60049 | 0.100 |
Why?
|
| Nature | 1 | 2011 | 15 | 0.100 |
Why?
|
| Dalteparin | 2 | 2008 | 44 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 2783 | 0.090 |
Why?
|
| Diagnostic Imaging | 4 | 2014 | 3541 | 0.090 |
Why?
|
| Anticonvulsants | 4 | 1990 | 1923 | 0.090 |
Why?
|
| Terminology as Topic | 4 | 1999 | 1539 | 0.090 |
Why?
|
| Angiodysplasia | 1 | 2011 | 22 | 0.090 |
Why?
|
| Canada | 4 | 2014 | 2139 | 0.090 |
Why?
|
| Cause of Death | 4 | 2019 | 3728 | 0.090 |
Why?
|
| Anesthesia, Inhalation | 6 | 1988 | 220 | 0.090 |
Why?
|
| Thrombectomy | 1 | 2016 | 671 | 0.090 |
Why?
|
| Blood-Brain Barrier | 4 | 1987 | 1033 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2008 | 1196 | 0.090 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 1133 | 0.090 |
Why?
|
| Heart-Assist Devices | 2 | 2020 | 1292 | 0.090 |
Why?
|
| Intubation, Intratracheal | 2 | 1999 | 1359 | 0.090 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2013 | 579 | 0.090 |
Why?
|
| Uric Acid | 2 | 1987 | 806 | 0.090 |
Why?
|
| Hemostasis, Surgical | 4 | 2000 | 127 | 0.090 |
Why?
|
| Cardiac Output | 2 | 1986 | 838 | 0.090 |
Why?
|
| Hospitals, University | 2 | 2005 | 569 | 0.090 |
Why?
|
| Elasticity | 2 | 2003 | 657 | 0.090 |
Why?
|
| Carotid Artery Thrombosis | 8 | 1983 | 50 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2008 | 1252 | 0.090 |
Why?
|
| Retinal Artery | 5 | 1982 | 109 | 0.090 |
Why?
|
| Comorbidity | 10 | 2016 | 10588 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2022 | 1882 | 0.090 |
Why?
|
| Acid-Base Equilibrium | 3 | 1981 | 181 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 773 | 0.090 |
Why?
|
| Xanthine Oxidase | 2 | 1987 | 69 | 0.090 |
Why?
|
| Nicotinic Acids | 3 | 1986 | 33 | 0.090 |
Why?
|
| Locus Coeruleus | 2 | 1986 | 243 | 0.090 |
Why?
|
| Proteins | 1 | 2005 | 6006 | 0.090 |
Why?
|
| Dihydropyridines | 1 | 1990 | 67 | 0.090 |
Why?
|
| Hospitalization | 2 | 2020 | 10844 | 0.090 |
Why?
|
| Electroshock | 1 | 1990 | 120 | 0.090 |
Why?
|
| Cerebral Veins | 3 | 1994 | 158 | 0.090 |
Why?
|
| Isoflurane | 3 | 1988 | 384 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2006 | 1141 | 0.080 |
Why?
|
| Postoperative Period | 5 | 2011 | 1830 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2012 | 36849 | 0.080 |
Why?
|
| Hyperventilation | 1 | 1989 | 78 | 0.080 |
Why?
|
| Biomedical Technology | 1 | 2011 | 210 | 0.080 |
Why?
|
| Relaxation | 1 | 2009 | 51 | 0.080 |
Why?
|
| Premedication | 1 | 1990 | 246 | 0.080 |
Why?
|
| Disease Progression | 7 | 2018 | 13646 | 0.080 |
Why?
|
| Carotid Stenosis | 2 | 2015 | 862 | 0.080 |
Why?
|
| Lactates | 7 | 1973 | 401 | 0.080 |
Why?
|
| Hematocrit | 3 | 2024 | 625 | 0.080 |
Why?
|
| Hydrogen | 1 | 1990 | 171 | 0.080 |
Why?
|
| Gastritis, Hypertrophic | 1 | 1988 | 9 | 0.080 |
Why?
|
| Vasoconstriction | 5 | 2000 | 594 | 0.080 |
Why?
|
| Coma | 1 | 2013 | 487 | 0.080 |
Why?
|
| Aerospace Medicine | 1 | 2010 | 95 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 1 | 1992 | 962 | 0.080 |
Why?
|
| Accidents | 1 | 2010 | 164 | 0.080 |
Why?
|
| Cooperative Behavior | 3 | 2024 | 1515 | 0.080 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2009 | 60 | 0.080 |
Why?
|
| Hemangiosarcoma | 1 | 2011 | 216 | 0.080 |
Why?
|
| Diagnosis, Differential | 8 | 2010 | 13020 | 0.080 |
Why?
|
| Random Allocation | 3 | 2008 | 2397 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2015 | 22296 | 0.080 |
Why?
|
| Immune Tolerance | 7 | 1994 | 2324 | 0.080 |
Why?
|
| Phosphates | 1 | 1992 | 765 | 0.080 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2009 | 63 | 0.080 |
Why?
|
| Monitoring, Physiologic | 8 | 1986 | 1795 | 0.080 |
Why?
|
| Equipment Design | 3 | 2009 | 3529 | 0.080 |
Why?
|
| Heart Septum | 1 | 2009 | 304 | 0.080 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 455 | 0.080 |
Why?
|
| Equipment Safety | 1 | 2009 | 250 | 0.080 |
Why?
|
| Adenosine Triphosphate | 7 | 1992 | 2002 | 0.080 |
Why?
|
| Heart Arrest | 3 | 2016 | 1516 | 0.080 |
Why?
|
| Vasodilator Agents | 3 | 2014 | 990 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2016 | 2505 | 0.070 |
Why?
|
| Naphthyridines | 1 | 1990 | 181 | 0.070 |
Why?
|
| Reward | 1 | 2015 | 984 | 0.070 |
Why?
|
| Actuarial Analysis | 4 | 1999 | 372 | 0.070 |
Why?
|
| Viremia | 2 | 2021 | 725 | 0.070 |
Why?
|
| Infarction | 10 | 1976 | 247 | 0.070 |
Why?
|
| Pulmonary Atresia | 1 | 2009 | 159 | 0.070 |
Why?
|
| Cardiomyopathies | 2 | 2011 | 2056 | 0.070 |
Why?
|
| Chronic Disease | 5 | 2011 | 9379 | 0.070 |
Why?
|
| Compliance | 1 | 2007 | 100 | 0.070 |
Why?
|
| Pilot Projects | 5 | 2018 | 8731 | 0.070 |
Why?
|
| Heparin | 8 | 1993 | 1636 | 0.070 |
Why?
|
| Hypertension | 8 | 2015 | 8615 | 0.070 |
Why?
|
| Paresis | 1 | 2008 | 177 | 0.070 |
Why?
|
| Social Responsibility | 1 | 2010 | 384 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1998 | 370 | 0.070 |
Why?
|
| Publishing | 1 | 1994 | 836 | 0.070 |
Why?
|
| Emergencies | 3 | 2010 | 1219 | 0.070 |
Why?
|
| Penicillins | 1 | 1990 | 406 | 0.070 |
Why?
|
| Patient Readmission | 3 | 2021 | 3312 | 0.070 |
Why?
|
| Community Health Services | 1 | 2012 | 659 | 0.070 |
Why?
|
| Gastritis | 1 | 1988 | 199 | 0.070 |
Why?
|
| Kidney Diseases | 2 | 2008 | 2103 | 0.070 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2008 | 263 | 0.070 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2011 | 1126 | 0.070 |
Why?
|
| Intracranial Pressure | 1 | 1989 | 325 | 0.070 |
Why?
|
| Radiotherapy | 2 | 2010 | 1509 | 0.070 |
Why?
|
| Boston | 2 | 2016 | 9371 | 0.070 |
Why?
|
| Blood Volume | 2 | 2015 | 546 | 0.070 |
Why?
|
| Cryosurgery | 1 | 2011 | 477 | 0.070 |
Why?
|
| Gadolinium | 1 | 2011 | 965 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2006 | 12166 | 0.070 |
Why?
|
| Paraparesis | 1 | 2006 | 15 | 0.070 |
Why?
|
| Drug Costs | 1 | 2014 | 1196 | 0.070 |
Why?
|
| Benzylamines | 1 | 2007 | 251 | 0.070 |
Why?
|
| Azetidines | 1 | 2007 | 143 | 0.070 |
Why?
|
| Thoracic Neoplasms | 1 | 2008 | 269 | 0.070 |
Why?
|
| Temperature | 2 | 2011 | 2235 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2007 | 361 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 2009 | 463 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1337 | 0.060 |
Why?
|
| Collateral Circulation | 10 | 1988 | 291 | 0.060 |
Why?
|
| Cerebral Arterial Diseases | 6 | 1985 | 82 | 0.060 |
Why?
|
| Aspirin | 5 | 2008 | 3135 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2010 | 4039 | 0.060 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 500 | 0.060 |
Why?
|
| Cerebellum | 4 | 1982 | 1514 | 0.060 |
Why?
|
| Nervous System Diseases | 6 | 2002 | 1664 | 0.060 |
Why?
|
| Intracellular Fluid | 3 | 1986 | 201 | 0.060 |
Why?
|
| Kidney Neoplasms | 2 | 2015 | 4303 | 0.060 |
Why?
|
| Retinal Diseases | 5 | 1982 | 710 | 0.060 |
Why?
|
| Survivors | 2 | 2013 | 2382 | 0.060 |
Why?
|
| Ophthalmoplegia | 1 | 1986 | 168 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 7 | 1993 | 2709 | 0.060 |
Why?
|
| Partial Pressure | 8 | 1980 | 248 | 0.060 |
Why?
|
| Veins | 3 | 1987 | 768 | 0.060 |
Why?
|
| Tissue Array Analysis | 1 | 2007 | 551 | 0.060 |
Why?
|
| Peer Review, Research | 1 | 2008 | 344 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 784 | 0.060 |
Why?
|
| Rabbits | 11 | 1990 | 4781 | 0.060 |
Why?
|
| Leg | 3 | 2003 | 1088 | 0.060 |
Why?
|
| Trigeminal Neuralgia | 1 | 1986 | 107 | 0.060 |
Why?
|
| Quality of Life | 3 | 2008 | 13503 | 0.060 |
Why?
|
| Xenon Radioisotopes | 5 | 1987 | 33 | 0.060 |
Why?
|
| Immunoblotting | 2 | 1998 | 1647 | 0.060 |
Why?
|
| Saimiri | 6 | 1986 | 337 | 0.060 |
Why?
|
| Internationality | 1 | 2010 | 1008 | 0.060 |
Why?
|
| Tensile Strength | 2 | 2002 | 335 | 0.060 |
Why?
|
| Cyclosporine | 3 | 2002 | 779 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2011 | 1813 | 0.060 |
Why?
|
| Cardiotonic Agents | 2 | 2007 | 544 | 0.060 |
Why?
|
| Child | 26 | 2014 | 80891 | 0.060 |
Why?
|
| Robotics | 1 | 2011 | 825 | 0.060 |
Why?
|
| Dipyridamole | 2 | 1982 | 143 | 0.060 |
Why?
|
| Creatinine | 1 | 2010 | 1915 | 0.060 |
Why?
|
| Catheterization | 5 | 2003 | 1431 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2016 | 5375 | 0.060 |
Why?
|
| Missouri | 1 | 2004 | 113 | 0.060 |
Why?
|
| Vasomotor System | 3 | 1975 | 208 | 0.060 |
Why?
|
| Intensive Care Units | 2 | 2015 | 3801 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1445 | 0.060 |
Why?
|
| Selection Bias | 1 | 2006 | 360 | 0.060 |
Why?
|
| Spinal Cord Ischemia | 2 | 2006 | 94 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3922 | 0.060 |
Why?
|
| Disease Models, Animal | 13 | 2008 | 18362 | 0.060 |
Why?
|
| Retreatment | 2 | 2020 | 600 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 2074 | 0.060 |
Why?
|
| Hepacivirus | 2 | 2021 | 1342 | 0.050 |
Why?
|
| Ticlopidine | 1 | 2008 | 730 | 0.050 |
Why?
|
| Pedigree | 2 | 2007 | 4544 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 1006 | 0.050 |
Why?
|
| Referral and Consultation | 2 | 2014 | 3627 | 0.050 |
Why?
|
| Ventricular Dysfunction | 1 | 2004 | 144 | 0.050 |
Why?
|
| Thoracic Injuries | 1 | 2006 | 288 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2018 | 5099 | 0.050 |
Why?
|
| Tetralogy of Fallot | 1 | 2009 | 628 | 0.050 |
Why?
|
| Life Tables | 4 | 2006 | 368 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 710 | 0.050 |
Why?
|
| Diastole | 2 | 2011 | 784 | 0.050 |
Why?
|
| Subtraction Technique | 2 | 1983 | 519 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 1994 | 1469 | 0.050 |
Why?
|
| Ligation | 5 | 2009 | 447 | 0.050 |
Why?
|
| Complementary Therapies | 1 | 2007 | 487 | 0.050 |
Why?
|
| Carbamazepine | 1 | 1984 | 224 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2004 | 227 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 1988 | 936 | 0.050 |
Why?
|
| Focus Groups | 1 | 2009 | 1453 | 0.050 |
Why?
|
| Genotype | 2 | 2007 | 13042 | 0.050 |
Why?
|
| Anemia, Hemolytic | 1 | 1984 | 164 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1890 | 0.050 |
Why?
|
| Fatigue | 1 | 2010 | 1555 | 0.050 |
Why?
|
| Tissue Donors | 4 | 2021 | 2389 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2004 | 452 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 5 | 1992 | 1362 | 0.050 |
Why?
|
| DNA Glycosylases | 1 | 2003 | 125 | 0.050 |
Why?
|
| Angioplasty, Balloon | 2 | 2007 | 592 | 0.050 |
Why?
|
| Analysis of Variance | 5 | 2011 | 6241 | 0.050 |
Why?
|
| Chest Pain | 1 | 2009 | 1099 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2009 | 957 | 0.050 |
Why?
|
| Ibuprofen | 1 | 1983 | 229 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2022 | 119 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 1989 | 1033 | 0.050 |
Why?
|
| Infection Control | 2 | 1999 | 985 | 0.050 |
Why?
|
| Heart Bypass, Left | 1 | 2001 | 6 | 0.050 |
Why?
|
| Brain Injuries | 2 | 2013 | 2059 | 0.050 |
Why?
|
| Patient Preference | 1 | 2010 | 947 | 0.050 |
Why?
|
| Risk Adjustment | 2 | 2019 | 603 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2007 | 2342 | 0.050 |
Why?
|
| Oxygenators | 1 | 2001 | 36 | 0.050 |
Why?
|
| Decision Trees | 2 | 2014 | 509 | 0.050 |
Why?
|
| Dexamethasone | 2 | 1984 | 1965 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2015 | 3243 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2005 | 374 | 0.050 |
Why?
|
| Naloxone | 2 | 1987 | 372 | 0.050 |
Why?
|
| Rupture, Spontaneous | 5 | 1988 | 365 | 0.050 |
Why?
|
| Bradykinin | 3 | 1997 | 205 | 0.050 |
Why?
|
| Hypoxia, Brain | 2 | 1979 | 139 | 0.050 |
Why?
|
| Enflurane | 3 | 1988 | 16 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2006 | 2663 | 0.050 |
Why?
|
| Microcirculation | 4 | 1987 | 1282 | 0.050 |
Why?
|
| Mutation | 1 | 2006 | 30228 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5538 | 0.050 |
Why?
|
| Exons | 1 | 2007 | 2392 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 1990 | 896 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2007 | 12805 | 0.050 |
Why?
|
| Rats | 12 | 2000 | 23835 | 0.050 |
Why?
|
| Smoking | 3 | 2015 | 9111 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 1568 | 0.050 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 8562 | 0.050 |
Why?
|
| Physician's Role | 1 | 2008 | 926 | 0.050 |
Why?
|
| T-Lymphocytes | 5 | 1992 | 10267 | 0.050 |
Why?
|
| Anterior Horn Cells | 1 | 2000 | 17 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2004 | 2363 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2008 | 879 | 0.040 |
Why?
|
| Diabetes Mellitus | 3 | 2015 | 5891 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2005 | 841 | 0.040 |
Why?
|
| Respiration, Artificial | 4 | 2011 | 2721 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2004 | 554 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2002 | 442 | 0.040 |
Why?
|
| Papaverine | 1 | 2000 | 45 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2009 | 1335 | 0.040 |
Why?
|
| Retinal Vein | 2 | 1979 | 47 | 0.040 |
Why?
|
| Computers | 1 | 1982 | 592 | 0.040 |
Why?
|
| Rats, Inbred Strains | 3 | 1990 | 2087 | 0.040 |
Why?
|
| Transplantation, Heterologous | 5 | 2009 | 2394 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20224 | 0.040 |
Why?
|
| Kidney Transplantation | 5 | 1994 | 4300 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 3200 | 0.040 |
Why?
|
| Phenytoin | 3 | 1990 | 190 | 0.040 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2002 | 220 | 0.040 |
Why?
|
| Phenoxybenzamine | 2 | 1980 | 53 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2006 | 809 | 0.040 |
Why?
|
| Patient Participation | 1 | 2008 | 1448 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 1937 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 1422 | 0.040 |
Why?
|
| Holmium | 1 | 1999 | 29 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2008 | 1238 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2010 | 1765 | 0.040 |
Why?
|
| Pentylenetetrazole | 3 | 1987 | 72 | 0.040 |
Why?
|
| Sound | 2 | 2011 | 261 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2009 | 3411 | 0.040 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1979 | 98 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4120 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 2000 | 335 | 0.040 |
Why?
|
| Heart Rate | 2 | 2007 | 4218 | 0.040 |
Why?
|
| Pneumonia, Aspiration | 1 | 1999 | 145 | 0.040 |
Why?
|
| Body Fluids | 1 | 1980 | 322 | 0.040 |
Why?
|
| Forecasting | 3 | 2008 | 2948 | 0.040 |
Why?
|
| Credentialing | 1 | 2019 | 114 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1979 | 197 | 0.040 |
Why?
|
| Quinoxalines | 1 | 2000 | 297 | 0.040 |
Why?
|
| Meningeal Arteries | 1 | 1978 | 66 | 0.040 |
Why?
|
| Coronary Care Units | 1 | 1999 | 235 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 564 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2007 | 2593 | 0.040 |
Why?
|
| Cerebral Infarction | 4 | 1986 | 975 | 0.040 |
Why?
|
| Angioplasty, Laser | 1 | 1997 | 17 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2005 | 1376 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6085 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2000 | 452 | 0.040 |
Why?
|
| Medical Illustration | 1 | 1998 | 135 | 0.040 |
Why?
|
| Prosthesis Implantation | 2 | 2015 | 594 | 0.040 |
Why?
|
| Fibrosis | 1 | 2005 | 2077 | 0.040 |
Why?
|
| Sympathectomy | 1 | 1997 | 72 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 1992 | 510 | 0.040 |
Why?
|
| Child, Preschool | 15 | 2014 | 42650 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 1998 | 304 | 0.040 |
Why?
|
| Collagen | 1 | 2006 | 2646 | 0.040 |
Why?
|
| Kidney | 5 | 2007 | 7064 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 1985 | 1704 | 0.040 |
Why?
|
| Syndrome | 4 | 2011 | 3275 | 0.030 |
Why?
|
| Blood Coagulation | 2 | 1982 | 1161 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2021 | 888 | 0.030 |
Why?
|
| Hypocapnia | 1 | 1976 | 38 | 0.030 |
Why?
|
| Learning Curve | 1 | 2019 | 232 | 0.030 |
Why?
|
| Subarachnoid Space | 2 | 1993 | 79 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2018 | 475 | 0.030 |
Why?
|
| Lidocaine | 3 | 1977 | 545 | 0.030 |
Why?
|
| Pregnancy | 4 | 2020 | 30200 | 0.030 |
Why?
|
| Hydrocephalus | 2 | 1982 | 770 | 0.030 |
Why?
|
| Kidney Function Tests | 2 | 2010 | 681 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 281 | 0.030 |
Why?
|
| Pressoreceptors | 1 | 1976 | 99 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 1976 | 88 | 0.030 |
Why?
|
| California | 1 | 2020 | 1443 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2004 | 1525 | 0.030 |
Why?
|
| Rheology | 1 | 1977 | 348 | 0.030 |
Why?
|
| Heart Atria | 3 | 2011 | 1360 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2001 | 1696 | 0.030 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 1997 | 148 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 1309 | 0.030 |
Why?
|
| Demography | 1 | 2000 | 1642 | 0.030 |
Why?
|
| Homeostasis | 7 | 1989 | 3349 | 0.030 |
Why?
|
| Vascular Diseases | 3 | 1982 | 1161 | 0.030 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2016 | 86 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 4047 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 2005 | 1498 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 1997 | 253 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 1004 | 0.030 |
Why?
|
| Chimera | 3 | 1991 | 454 | 0.030 |
Why?
|
| Carotid Artery, External | 3 | 1986 | 37 | 0.030 |
Why?
|
| Myocardium | 2 | 1998 | 4788 | 0.030 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1975 | 96 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 1991 | 1355 | 0.030 |
Why?
|
| Phentolamine | 1 | 1974 | 102 | 0.030 |
Why?
|
| Catecholamines | 2 | 1973 | 390 | 0.030 |
Why?
|
| Krypton | 4 | 1987 | 21 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 3 | 2006 | 7463 | 0.030 |
Why?
|
| Ophthalmodynamometry | 3 | 1982 | 4 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 1985 | 946 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 3 | 1990 | 1629 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2008 | 3267 | 0.030 |
Why?
|
| Adenosine Diphosphate | 2 | 1992 | 422 | 0.030 |
Why?
|
| Sex Factors | 5 | 2007 | 10654 | 0.030 |
Why?
|
| Gene Expression | 1 | 2007 | 7598 | 0.030 |
Why?
|
| Analgesics | 1 | 2021 | 1070 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1997 | 709 | 0.030 |
Why?
|
| Nerve Degeneration | 3 | 1975 | 750 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 7145 | 0.030 |
Why?
|
| Pulmonary Medicine | 1 | 2016 | 223 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 463 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 2 | 1975 | 657 | 0.030 |
Why?
|
| Eye | 1 | 1978 | 712 | 0.030 |
Why?
|
| Awareness | 1 | 2018 | 653 | 0.030 |
Why?
|
| DNA | 1 | 2007 | 7211 | 0.030 |
Why?
|
| Infant | 11 | 2010 | 36510 | 0.030 |
Why?
|
| Lymphocyte Depletion | 3 | 1990 | 605 | 0.030 |
Why?
|
| Hemangioma, Cavernous | 1 | 1994 | 107 | 0.030 |
Why?
|
| Immunosuppressive Agents | 3 | 2009 | 4209 | 0.030 |
Why?
|
| Constriction, Pathologic | 4 | 1984 | 1104 | 0.030 |
Why?
|
| Radioisotopes | 4 | 1987 | 517 | 0.030 |
Why?
|
| Norepinephrine | 3 | 1986 | 900 | 0.030 |
Why?
|
| Radiation Chimera | 2 | 1989 | 216 | 0.030 |
Why?
|
| Muscle, Smooth | 2 | 1977 | 930 | 0.030 |
Why?
|
| Video Recording | 1 | 2018 | 974 | 0.030 |
Why?
|
| Retirement | 1 | 1994 | 198 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1987 | 1379 | 0.030 |
Why?
|
| Guanosine Diphosphate | 1 | 1992 | 79 | 0.030 |
Why?
|
| Antibody Formation | 3 | 1992 | 1393 | 0.030 |
Why?
|
| Heart Failure | 5 | 2008 | 11858 | 0.030 |
Why?
|
| Verapamil | 3 | 1987 | 242 | 0.030 |
Why?
|
| Hematology | 1 | 2016 | 244 | 0.030 |
Why?
|
| Pharyngitis | 1 | 2014 | 222 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 1972 | 91 | 0.030 |
Why?
|
| Hemostasis | 2 | 1986 | 468 | 0.030 |
Why?
|
| Clinical Trials as Topic | 5 | 1997 | 8051 | 0.020 |
Why?
|
| Japan | 2 | 2006 | 1418 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 7075 | 0.020 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1972 | 67 | 0.020 |
Why?
|
| Vasa Vasorum | 1 | 1991 | 25 | 0.020 |
Why?
|
| Optic Atrophy | 1 | 1972 | 79 | 0.020 |
Why?
|
| Mitral Valve Stenosis | 1 | 2014 | 342 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 1997 | 690 | 0.020 |
Why?
|
| Propranolol | 2 | 1986 | 493 | 0.020 |
Why?
|
| Kinetics | 3 | 2002 | 6333 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 5 | 1991 | 9261 | 0.020 |
Why?
|
| Phosphocreatine | 1 | 1992 | 261 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 1992 | 315 | 0.020 |
Why?
|
| Microscopy, Electron | 5 | 1974 | 2559 | 0.020 |
Why?
|
| Sheep | 2 | 2005 | 1451 | 0.020 |
Why?
|
| Population Surveillance | 2 | 2015 | 2598 | 0.020 |
Why?
|
| Septal Occluder Device | 1 | 2012 | 125 | 0.020 |
Why?
|
| Isoantigens | 2 | 1992 | 563 | 0.020 |
Why?
|
| Capillaries | 2 | 1994 | 756 | 0.020 |
Why?
|
| Ganglia | 1 | 2011 | 86 | 0.020 |
Why?
|
| Hemianopsia | 1 | 1972 | 121 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 732 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 1992 | 233 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 1992 | 394 | 0.020 |
Why?
|
| Hematoma, Epidural, Cranial | 2 | 1982 | 59 | 0.020 |
Why?
|
| Equipment Failure | 2 | 2004 | 585 | 0.020 |
Why?
|
| Israel | 1 | 2013 | 726 | 0.020 |
Why?
|
| Oxidation-Reduction | 3 | 1982 | 2225 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1992 | 538 | 0.020 |
Why?
|
| Isradipine | 1 | 1990 | 12 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 1993 | 627 | 0.020 |
Why?
|
| Muscle Contraction | 3 | 1985 | 1208 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2018 | 2740 | 0.020 |
Why?
|
| Neurons | 4 | 1986 | 9513 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2011 | 509 | 0.020 |
Why?
|
| Chemistry | 1 | 1990 | 327 | 0.020 |
Why?
|
| Nicardipine | 1 | 1990 | 60 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 2010 | 82 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 1990 | 94 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 4859 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1990 | 486 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 1992 | 1561 | 0.020 |
Why?
|
| Hematoma, Subdural | 2 | 1982 | 128 | 0.020 |
Why?
|
| Nitrous Oxide | 2 | 1984 | 166 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 2014 | 619 | 0.020 |
Why?
|
| Calcinosis | 2 | 1995 | 1481 | 0.020 |
Why?
|
| Mannitol | 2 | 1987 | 177 | 0.020 |
Why?
|
| Acidosis | 3 | 1980 | 271 | 0.020 |
Why?
|
| Lysosomes | 2 | 1974 | 939 | 0.020 |
Why?
|
| Perioperative Period | 1 | 2011 | 252 | 0.020 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2009 | 52 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2007 | 13052 | 0.020 |
Why?
|
| Renal Dialysis | 2 | 2010 | 1802 | 0.020 |
Why?
|
| Vascular Grafting | 1 | 2011 | 163 | 0.020 |
Why?
|
| Hemangioma | 1 | 1994 | 727 | 0.020 |
Why?
|
| Decision Making | 2 | 2018 | 3953 | 0.020 |
Why?
|
| Propofol | 1 | 1995 | 608 | 0.020 |
Why?
|
| Blindness | 4 | 1977 | 587 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1990 | 332 | 0.020 |
Why?
|
| Headache | 4 | 1987 | 1262 | 0.020 |
Why?
|
| Lymphocytes | 2 | 1990 | 2611 | 0.020 |
Why?
|
| Gastric Acid | 1 | 1988 | 99 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3064 | 0.020 |
Why?
|
| Oxygen | 8 | 1980 | 4273 | 0.020 |
Why?
|
| Torsion, Mechanical | 1 | 2008 | 15 | 0.020 |
Why?
|
| Asia | 1 | 2010 | 627 | 0.020 |
Why?
|
| Psychometrics | 1 | 2018 | 3069 | 0.020 |
Why?
|
| Models, Biological | 2 | 1992 | 9493 | 0.020 |
Why?
|
| Serotonin | 3 | 1985 | 1045 | 0.020 |
Why?
|
| Dextrans | 2 | 1967 | 574 | 0.020 |
Why?
|
| Lens Subluxation | 1 | 2008 | 23 | 0.020 |
Why?
|
| Synapses | 2 | 1974 | 1766 | 0.020 |
Why?
|
| Xenon | 5 | 1975 | 120 | 0.020 |
Why?
|
| Renal Replacement Therapy | 1 | 2010 | 283 | 0.020 |
Why?
|
| Biological Factors | 1 | 1989 | 158 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2014 | 1476 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1992 | 1866 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1585 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7861 | 0.020 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2009 | 218 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 478 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3906 | 0.020 |
Why?
|
| Clonazepam | 1 | 1987 | 135 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 1988 | 134 | 0.020 |
Why?
|
| Prosthesis Fitting | 1 | 2007 | 75 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 26375 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2008 | 289 | 0.020 |
Why?
|
| Holistic Health | 1 | 2007 | 48 | 0.020 |
Why?
|
| Free Radicals | 1 | 1987 | 238 | 0.020 |
Why?
|
| Nevus, Pigmented | 1 | 1989 | 221 | 0.020 |
Why?
|
| Pericardium | 1 | 2011 | 679 | 0.020 |
Why?
|
| Polyps | 1 | 1988 | 200 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1967 | 676 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 2011 | 647 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2008 | 687 | 0.020 |
Why?
|
| Chordae Tendineae | 1 | 2006 | 39 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 3131 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2016 | 1222 | 0.020 |
Why?
|
| Femoral Artery | 2 | 1973 | 829 | 0.020 |
Why?
|
| Disease-Free Survival | 3 | 2004 | 6856 | 0.020 |
Why?
|
| Piperidines | 1 | 1995 | 1659 | 0.020 |
Why?
|
| Autopsy | 2 | 2004 | 1013 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 14784 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 1303 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1992 | 6234 | 0.020 |
Why?
|
| Carotid Body Tumor | 1 | 1986 | 34 | 0.020 |
Why?
|
| Hypotension | 3 | 2003 | 889 | 0.020 |
Why?
|
| Stereotyping | 1 | 2008 | 242 | 0.020 |
Why?
|
| Relaxation Therapy | 1 | 2007 | 181 | 0.020 |
Why?
|
| Aneurysm, Infected | 1 | 2006 | 81 | 0.020 |
Why?
|
| Pupil | 1 | 1986 | 146 | 0.020 |
Why?
|
| Urethane | 2 | 1975 | 38 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1992 | 1795 | 0.020 |
Why?
|
| Heart-Lung Machine | 1 | 2005 | 44 | 0.020 |
Why?
|
| Morbidity | 1 | 2011 | 1758 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1317 | 0.020 |
Why?
|
| Axons | 4 | 2000 | 1678 | 0.020 |
Why?
|
| Cost Control | 1 | 2008 | 627 | 0.020 |
Why?
|
| Epilepsy | 3 | 1993 | 3326 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2008 | 375 | 0.020 |
Why?
|
| Cell Communication | 1 | 1992 | 1660 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 11918 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 1986 | 145 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1986 | 243 | 0.020 |
Why?
|
| Death | 1 | 1990 | 683 | 0.020 |
Why?
|
| Receptors, Adrenergic | 2 | 1977 | 155 | 0.020 |
Why?
|
| Diplopia | 1 | 1986 | 217 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 2491 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 2957 | 0.010 |
Why?
|
| Coronary Restenosis | 1 | 2007 | 396 | 0.010 |
Why?
|
| Neck | 3 | 1978 | 736 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 1131 | 0.010 |
Why?
|
| Urea | 1 | 1967 | 446 | 0.010 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2006 | 262 | 0.010 |
Why?
|
| Rodentia | 1 | 1985 | 262 | 0.010 |
Why?
|
| Life Expectancy | 2 | 2006 | 1249 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 1992 | 5496 | 0.010 |
Why?
|
| Lymphotoxin-beta | 1 | 2003 | 14 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1972 | 1325 | 0.010 |
Why?
|
| Infrared Rays | 2 | 1975 | 249 | 0.010 |
Why?
|
| Auscultation | 2 | 1975 | 38 | 0.010 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2003 | 35 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2003 | 68 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 94 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 1991 | 5900 | 0.010 |
Why?
|
| Graft vs Host Disease | 3 | 1993 | 3044 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2003 | 114 | 0.010 |
Why?
|
| Glomus Jugulare Tumor | 1 | 1983 | 35 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1992 | 2058 | 0.010 |
Why?
|
| Synaptic Vesicles | 2 | 1974 | 190 | 0.010 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1983 | 47 | 0.010 |
Why?
|
| Heart Sounds | 1 | 1982 | 17 | 0.010 |
Why?
|
| Reference Values | 1 | 2010 | 4941 | 0.010 |
Why?
|
| Blood Platelets | 4 | 1982 | 2476 | 0.010 |
Why?
|
| Brachiocephalic Trunk | 1 | 1982 | 41 | 0.010 |
Why?
|
| Golgi Apparatus | 2 | 1974 | 405 | 0.010 |
Why?
|
| Leukocytes | 1 | 1991 | 2030 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2004 | 562 | 0.010 |
Why?
|
| Spasm | 3 | 1972 | 131 | 0.010 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2003 | 93 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2010 | 1187 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2006 | 1046 | 0.010 |
Why?
|
| Hemiplegia | 2 | 1973 | 137 | 0.010 |
Why?
|
| Research | 1 | 2011 | 1981 | 0.010 |
Why?
|
| Pyruvates | 2 | 1973 | 83 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2007 | 2281 | 0.010 |
Why?
|
| Subdural Space | 1 | 1982 | 38 | 0.010 |
Why?
|
| Ophthalmoscopy | 2 | 1974 | 172 | 0.010 |
Why?
|
| Brain Neoplasms | 3 | 1994 | 9198 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1982 | 77 | 0.010 |
Why?
|
| Radiology | 1 | 2016 | 2117 | 0.010 |
Why?
|
| Palliative Care | 1 | 1997 | 3643 | 0.010 |
Why?
|
| Dendrites | 2 | 1974 | 472 | 0.010 |
Why?
|
| Ion Channels | 1 | 1986 | 1044 | 0.010 |
Why?
|
| Brain Diseases | 1 | 1991 | 1552 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2877 | 0.010 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1984 | 235 | 0.010 |
Why?
|
| Phlebography | 1 | 1982 | 326 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1982 | 575 | 0.010 |
Why?
|
| Silicones | 2 | 1976 | 228 | 0.010 |
Why?
|
| Bacteremia | 1 | 2008 | 985 | 0.010 |
Why?
|
| Penicillin G | 1 | 1980 | 40 | 0.010 |
Why?
|
| Ribosomes | 2 | 1974 | 499 | 0.010 |
Why?
|
| Cardiac Output, Low | 1 | 2001 | 191 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 588 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2011 | 3581 | 0.010 |
Why?
|
| Ear, Middle | 1 | 1983 | 341 | 0.010 |
Why?
|
| Alkalosis | 1 | 1980 | 55 | 0.010 |
Why?
|
| Posture | 2 | 1979 | 956 | 0.010 |
Why?
|
| Orbit | 2 | 1979 | 459 | 0.010 |
Why?
|
| Indicator Dilution Techniques | 1 | 1980 | 43 | 0.010 |
Why?
|
| Prevalence | 2 | 2011 | 15872 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 2663 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4921 | 0.010 |
Why?
|
| Necrosis | 1 | 2004 | 1621 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1989 | 1253 | 0.010 |
Why?
|
| Embolism | 2 | 1981 | 401 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1988 | 1180 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1982 | 376 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2013 | 3476 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1980 | 174 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1982 | 962 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1992 | 0.010 |
Why?
|
| Microscopy | 2 | 1975 | 909 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1837 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1965 | 1110 | 0.010 |
Why?
|
| Horner Syndrome | 1 | 1979 | 35 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1992 | 4427 | 0.010 |
Why?
|
| Lasers | 1 | 1984 | 952 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2000 | 380 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 2000 | 318 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2007 | 12456 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1794 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1982 | 660 | 0.010 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 1999 | 69 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1980 | 699 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3252 | 0.010 |
Why?
|
| Sulfinpyrazone | 1 | 1978 | 15 | 0.010 |
Why?
|
| Dilatation | 1 | 1980 | 313 | 0.010 |
Why?
|
| Calcium | 3 | 1988 | 5794 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1986 | 1346 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2003 | 483 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16721 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 1995 | 3836 | 0.010 |
Why?
|
| Lung | 1 | 1997 | 10089 | 0.010 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 1979 | 110 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 2 | 1974 | 1131 | 0.010 |
Why?
|
| Epilepsies, Partial | 1 | 1982 | 435 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2009 | 2894 | 0.010 |
Why?
|
| Health Status | 1 | 2011 | 4094 | 0.010 |
Why?
|
| NADP | 1 | 1979 | 230 | 0.010 |
Why?
|
| Hindlimb | 1 | 2000 | 516 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 2 | 1972 | 545 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 1986 | 1339 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 2337 | 0.010 |
Why?
|
| Neurologic Examination | 2 | 1988 | 916 | 0.010 |
Why?
|
| Contrast Media | 2 | 1999 | 5336 | 0.010 |
Why?
|
| Mice | 8 | 1992 | 82017 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2008 | 2693 | 0.010 |
Why?
|
| Shock | 1 | 1980 | 316 | 0.010 |
Why?
|
| Mice, Inbred Strains | 2 | 1990 | 1769 | 0.010 |
Why?
|
| Blood Pressure Determination | 2 | 1975 | 646 | 0.010 |
Why?
|
| Calibration | 1 | 1980 | 823 | 0.010 |
Why?
|
| Reserpine | 1 | 1977 | 63 | 0.010 |
Why?
|
| Mississippi | 1 | 1977 | 94 | 0.010 |
Why?
|
| Blood | 1 | 1980 | 597 | 0.010 |
Why?
|
| Aminophylline | 1 | 1977 | 41 | 0.010 |
Why?
|
| Subclavian Artery | 1 | 1978 | 138 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1990 | 4411 | 0.010 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1977 | 121 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1977 | 57 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1992 | 1438 | 0.010 |
Why?
|
| History of Medicine | 1 | 1977 | 42 | 0.010 |
Why?
|
| Thalamic Nuclei | 1 | 1977 | 111 | 0.010 |
Why?
|
| Acid Phosphatase | 2 | 1974 | 139 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 1993 | 26411 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1977 | 385 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2008 | 2589 | 0.010 |
Why?
|
| Algorithms | 2 | 2009 | 14154 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1614 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1977 | 73 | 0.010 |
Why?
|
| Photomicrography | 2 | 1967 | 72 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1976 | 71 | 0.010 |
Why?
|
| Nitric Oxide | 3 | 1992 | 2144 | 0.010 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1976 | 18 | 0.010 |
Why?
|
| Cysts | 1 | 1982 | 685 | 0.010 |
Why?
|
| Nucleotides, Cyclic | 1 | 1977 | 83 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1990 | 3112 | 0.010 |
Why?
|
| Blood Gas Analysis | 2 | 1975 | 384 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 1609 | 0.010 |
Why?
|
| Cell Count | 1 | 2000 | 1833 | 0.010 |
Why?
|
| Albuterol | 1 | 1977 | 211 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4588 | 0.010 |
Why?
|
| Fever | 1 | 1984 | 1620 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1983 | 2362 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 1976 | 98 | 0.010 |
Why?
|
| Malignant Hyperthermia | 1 | 1975 | 72 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 1739 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2002 | 1309 | 0.010 |
Why?
|
| Blood Volume Determination | 1 | 1975 | 41 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 1999 | 952 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1981 | 1058 | 0.010 |
Why?
|
| Methyl Ethers | 1 | 1976 | 196 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1984 | 1417 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 5 | 1991 | 22355 | 0.010 |
Why?
|
| Meningioma | 1 | 1984 | 1221 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3794 | 0.010 |
Why?
|
| Scalp | 1 | 1978 | 391 | 0.010 |
Why?
|
| Mitochondrial Swelling | 1 | 1974 | 15 | 0.010 |
Why?
|
| Tissue Preservation | 1 | 1995 | 173 | 0.010 |
Why?
|
| Nissl Bodies | 1 | 1974 | 16 | 0.010 |
Why?
|
| Palpation | 1 | 1975 | 166 | 0.010 |
Why?
|
| Hemosiderin | 1 | 1994 | 41 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1974 | 89 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1971 | 1882 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1980 | 1244 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1982 | 1926 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1977 | 550 | 0.010 |
Why?
|
| Placebos | 1 | 1978 | 1668 | 0.010 |
Why?
|
| Software | 1 | 2008 | 4453 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1982 | 6318 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1976 | 277 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1976 | 460 | 0.010 |
Why?
|
| Brain Stem | 1 | 1979 | 862 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1997 | 1998 | 0.010 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1972 | 35 | 0.010 |
Why?
|
| Methacholine Compounds | 1 | 1972 | 35 | 0.010 |
Why?
|
| Nerve Endings | 1 | 1973 | 105 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 1975 | 560 | 0.010 |
Why?
|
| Fentanyl | 1 | 1976 | 450 | 0.010 |
Why?
|
| Cytoplasm | 2 | 1974 | 1502 | 0.010 |
Why?
|
| Species Specificity | 2 | 1968 | 2417 | 0.010 |
Why?
|
| Muscles | 1 | 1978 | 1582 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1976 | 769 | 0.010 |
Why?
|
| Esterases | 1 | 1972 | 89 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 9063 | 0.010 |
Why?
|
| Purinones | 1 | 1992 | 13 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1977 | 866 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1974 | 565 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2000 | 1879 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 1972 | 178 | 0.010 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 1992 | 56 | 0.010 |
Why?
|
| Extracorporeal Circulation | 1 | 1972 | 181 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1990 | 5713 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 706 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 1977 | 709 | 0.010 |
Why?
|
| Embolism, Fat | 1 | 1971 | 46 | 0.010 |
Why?
|
| Bone Marrow | 2 | 1993 | 2929 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1974 | 573 | 0.010 |
Why?
|
| Carbon | 1 | 1975 | 672 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1992 | 862 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1991 | 140 | 0.010 |
Why?
|
| Renal Artery | 1 | 1972 | 353 | 0.010 |
Why?
|
| Histamine | 1 | 1972 | 499 | 0.010 |
Why?
|
| Killer Cells, Natural | 2 | 1990 | 2206 | 0.010 |
Why?
|
| Melanoma | 1 | 1989 | 5705 | 0.010 |
Why?
|
| Colorimetry | 1 | 1971 | 151 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1972 | 629 | 0.010 |
Why?
|
| Obesity | 2 | 2003 | 13084 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1986 | 6740 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1992 | 1065 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 1976 | 1086 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1972 | 413 | 0.010 |
Why?
|
| Motor Activity | 1 | 2000 | 2720 | 0.010 |
Why?
|
| Cross Infection | 1 | 1999 | 1426 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1972 | 412 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 1976 | 1304 | 0.010 |
Why?
|
| Uridine Triphosphate | 1 | 1989 | 29 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1991 | 826 | 0.010 |
Why?
|
| Hypotension, Controlled | 1 | 1969 | 16 | 0.010 |
Why?
|
| Thymectomy | 1 | 1990 | 200 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1991 | 306 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1972 | 634 | 0.010 |
Why?
|
| Eosinophils | 1 | 1974 | 953 | 0.010 |
Why?
|
| Angiotensin II | 1 | 1972 | 847 | 0.010 |
Why?
|
| Migraine Disorders | 2 | 1979 | 1713 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1990 | 435 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7599 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 4981 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1991 | 716 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1989 | 229 | 0.010 |
Why?
|
| Pressure | 1 | 1972 | 1172 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1994 | 687 | 0.010 |
Why?
|
| Epinephrine | 1 | 1972 | 794 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 2176 | 0.000 |
Why?
|
| Cell Nucleus | 2 | 1974 | 2886 | 0.000 |
Why?
|
| Retinal Vessels | 1 | 1975 | 864 | 0.000 |
Why?
|
| Calcimycin | 1 | 1988 | 214 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1979 | 1925 | 0.000 |
Why?
|
| Crosses, Genetic | 1 | 1989 | 753 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1972 | 1468 | 0.000 |
Why?
|
| Skin | 2 | 1991 | 4499 | 0.000 |
Why?
|
| Nitroprusside | 1 | 1988 | 272 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 4168 | 0.000 |
Why?
|
| Haplotypes | 1 | 1994 | 2724 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1993 | 2226 | 0.000 |
Why?
|
| Physiology, Comparative | 1 | 1967 | 8 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1990 | 3407 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1978 | 8199 | 0.000 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9510 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1974 | 2636 | 0.000 |
Why?
|
| Injections, Intra-Arterial | 1 | 1986 | 181 | 0.000 |
Why?
|
| Actins | 1 | 1994 | 2059 | 0.000 |
Why?
|
| Complement System Proteins | 1 | 1989 | 738 | 0.000 |
Why?
|
| Carotid Body | 1 | 1986 | 26 | 0.000 |
Why?
|
| Protein Structure, Tertiary | 1 | 1993 | 3779 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7880 | 0.000 |
Why?
|
| Bicuculline | 1 | 1986 | 96 | 0.000 |
Why?
|
| Indicators and Reagents | 1 | 1987 | 455 | 0.000 |
Why?
|
| Convulsants | 1 | 1986 | 70 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1976 | 2714 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1990 | 1616 | 0.000 |
Why?
|
| Biological Assay | 1 | 1989 | 627 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1992 | 1894 | 0.000 |
Why?
|
| Dehydration | 1 | 1967 | 216 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1990 | 1266 | 0.000 |
Why?
|
| Hospital Bed Capacity | 1 | 1986 | 206 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1967 | 2172 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1967 | 584 | 0.000 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1993 | 945 | 0.000 |
Why?
|
| Body Temperature | 1 | 1967 | 781 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1986 | 1153 | 0.000 |
Why?
|
| Carotid Artery Injuries | 1 | 1983 | 96 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1982 | 190 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 12422 | 0.000 |
Why?
|
| Alleles | 1 | 1993 | 6892 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1985 | 773 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 13423 | 0.000 |
Why?
|
| Cells, Cultured | 2 | 1991 | 19022 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1986 | 1743 | 0.000 |
Why?
|
| Specialties, Surgical | 1 | 1986 | 393 | 0.000 |
Why?
|
| Tympanic Membrane | 1 | 1983 | 232 | 0.000 |
Why?
|
| Fluorocarbons | 1 | 1987 | 505 | 0.000 |
Why?
|
| Mitochondria | 1 | 1974 | 3675 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1967 | 2268 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 17626 | 0.000 |
Why?
|
| Biopsy | 1 | 1972 | 6808 | 0.000 |
Why?
|
| Biological Products | 1 | 1988 | 934 | 0.000 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1985 | 1493 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1965 | 1279 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1990 | 9562 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1967 | 2421 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1982 | 3055 | 0.000 |
Why?
|
| Spleen | 1 | 1982 | 2296 | 0.000 |
Why?
|
| Arteriosclerosis Obliterans | 1 | 1974 | 8 | 0.000 |
Why?
|
| Glucose | 1 | 1967 | 4352 | 0.000 |
Why?
|
| Eye Manifestations | 1 | 1974 | 10 | 0.000 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1975 | 98 | 0.000 |
Why?
|
| Norway | 1 | 1975 | 501 | 0.000 |
Why?
|
| Head | 1 | 1979 | 927 | 0.000 |
Why?
|
| Mathematics | 1 | 1975 | 704 | 0.000 |
Why?
|
| Face | 1 | 1979 | 1031 | 0.000 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 1972 | 3 | 0.000 |
Why?
|
| Periodicity | 1 | 1974 | 348 | 0.000 |
Why?
|
| Central Venous Pressure | 1 | 1972 | 80 | 0.000 |
Why?
|
| Lymphoma | 1 | 1982 | 1907 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1972 | 305 | 0.000 |
Why?
|
| Glucosyltransferases | 1 | 1972 | 94 | 0.000 |
Why?
|
| Electron Transport Complex IV | 1 | 1972 | 192 | 0.000 |
Why?
|
| Succinate Dehydrogenase | 1 | 1972 | 148 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1972 | 412 | 0.000 |
Why?
|
| Consciousness | 1 | 1976 | 602 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1972 | 864 | 0.000 |
Why?
|
| Respiration | 1 | 1975 | 1667 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1972 | 841 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1972 | 1081 | 0.000 |
Why?
|
| Neuroglia | 1 | 1974 | 960 | 0.000 |
Why?
|
| Sex | 1 | 1967 | 53 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1967 | 402 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1976 | 2906 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1974 | 3663 | 0.000 |
Why?
|
| Dementia | 1 | 1976 | 2729 | 0.000 |
Why?
|
| Retina | 1 | 1972 | 2661 | 0.000 |
Why?
|